Growth Metrics

Vivos (RDGL) Cash from Operations Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Vivos - - -3,105.00 -24.19%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -24.19%
Sep 30, 2025 -17.45%
Jun 30, 2025 -52.30%
Mar 31, 2025 -5.81%
Dec 31, 2024 -25.99%
Sep 30, 2024 -41.66%
Jun 30, 2024 -0.78%
Mar 31, 2024 -20.06%
Dec 31, 2023 -8.20%
Sep 30, 2023 -6.46%
Jun 30, 2023 -9.55%
Mar 31, 2023 -49.86%
Dec 31, 2022 -3.62%
Sep 30, 2022 -15.23%
Jun 30, 2022 -10.37%
Mar 31, 2022 -12.25%
Dec 31, 2021 23.82%
Sep 30, 2021 -35.91%
Jun 30, 2021 -92.62%
Mar 31, 2021 -61.40%
Dec 31, 2020 -30.69%
Sep 30, 2020 19.10%
Jun 30, 2020 21.87%
Mar 31, 2020 31.85%
Dec 31, 2019 58.62%
Sep 30, 2019 -27.22%
Jun 30, 2019 48.14%
Mar 31, 2019 22.01%
Dec 31, 2018 -1.05%
Sep 30, 2018 18.67%
Jun 30, 2018 44.34%
Mar 31, 2018 43.18%
Dec 31, 2017 21.99%
Sep 30, 2017 -125.66%
Jun 30, 2017 -14.62%
Mar 31, 2017 13.62%
Dec 31, 2016 -174.94%
Sep 30, 2016 118.86%
Jun 30, 2016 1.47%
Mar 31, 2016 -1.92%
Dec 31, 2015 -13.70%
Sep 30, 2015 41.31%
Jun 30, 2015 18.25%
Mar 31, 2015 2.06%
Dec 31, 2014 -7.07%
Sep 30, 2014 48.16%
Jun 30, 2014 -15.96%
Mar 31, 2014 -42.67%
Dec 31, 2013 52.75%
Sep 30, 2013 -4.69%